The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia- A Cost-Utility Analysis
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.263
https://www.valueinhealthjournal.com/article/S1098-3015(17)30597-1/fulltext
Title :
The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia- A Cost-Utility Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30597-1&doi=10.1016/j.jval.2017.08.263
First page :
A444
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
240